Autoimmune gastritis: Distinct histological and immunohistochemical findings before complete loss of oxyntic glands

Michael Torbenson, Susan C. Abraham, John Boitnott, John H. Yardley, Tsung-Teh Wu

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Autoimmune gastritis (AG) can be easily recognized when the histological features are fully developed, but recognizing AG before the complete loss of the oxyntic mucosa is more challenging. One feature of fully developed AG is enterochromaffin cell-like (ECL) hyperplasia, but its presence or absence in earlier stages of AG has not been fully evaluated. A retrospective study of biopsy specimens from 40 patients was performed; all of the patients were originally diagnosed with possible AG based on the presence of lymphocytic infiltration and damage to oxyntic glands and/or the presence of metaplastic epithelium that disproportionately involved the body mucosa. Nineteen cases had follow-up serological studies for anti-parietal cells and/or anti-intrinsic factor antibodies: 13 were positive and 6 negative. The remaining 21 cases were indeterminate because of incomplete testing. The histological findings were similar in the patients who were serologically positive and those who were indeterminate for AG. In all of these cases, the oxyntic mucosa showed lymphoplasmacytic infiltrates within the lamina propria with focal gland infiltration and damage. Sixty-five percent (22/34) of the cases showed intestinal and/or pyloric metaplasia, and 85% (29/34) showed parietal cell pseudohypertrophy. Chromogranin stains were performed in 11 of 13 cases with positive serological markers for AG, and all showed at least linear ECL cell hyperplasia. In contrast, none of the six cases with negative serological studies had linear ECL cell hyperplasia, P < .001. In conclusion, the following constellation of findings supports a diagnosis of AG before the complete loss of oxyntic mucosa: deep or diffuse lymphoplasmacytic infiltrates within the lamina propria with foci of gland infiltration and damage, epithelial metaplasia, parietal cell pseudohypertrophy, and ECL cell hyperplasia at the linear or greater level.

Original languageEnglish (US)
Pages (from-to)102-109
Number of pages8
JournalModern Pathology
Volume15
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Gastritis
Enterochromaffin-like Cells
Mucous Membrane
Hyperplasia
Metaplasia
Chromogranins
Intrinsic Factor
Coloring Agents
Epithelium
Retrospective Studies
Biopsy
Antibodies

Keywords

  • Autoimmune gastritis
  • Chromogranin
  • ECL-cell hyperplasia
  • Gastrin
  • Metaplasia
  • Stomach

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Autoimmune gastritis : Distinct histological and immunohistochemical findings before complete loss of oxyntic glands. / Torbenson, Michael; Abraham, Susan C.; Boitnott, John; Yardley, John H.; Wu, Tsung-Teh.

In: Modern Pathology, Vol. 15, No. 2, 2002, p. 102-109.

Research output: Contribution to journalArticle

Torbenson, Michael ; Abraham, Susan C. ; Boitnott, John ; Yardley, John H. ; Wu, Tsung-Teh. / Autoimmune gastritis : Distinct histological and immunohistochemical findings before complete loss of oxyntic glands. In: Modern Pathology. 2002 ; Vol. 15, No. 2. pp. 102-109.
@article{4a1262191909433cb389cf540d548782,
title = "Autoimmune gastritis: Distinct histological and immunohistochemical findings before complete loss of oxyntic glands",
abstract = "Autoimmune gastritis (AG) can be easily recognized when the histological features are fully developed, but recognizing AG before the complete loss of the oxyntic mucosa is more challenging. One feature of fully developed AG is enterochromaffin cell-like (ECL) hyperplasia, but its presence or absence in earlier stages of AG has not been fully evaluated. A retrospective study of biopsy specimens from 40 patients was performed; all of the patients were originally diagnosed with possible AG based on the presence of lymphocytic infiltration and damage to oxyntic glands and/or the presence of metaplastic epithelium that disproportionately involved the body mucosa. Nineteen cases had follow-up serological studies for anti-parietal cells and/or anti-intrinsic factor antibodies: 13 were positive and 6 negative. The remaining 21 cases were indeterminate because of incomplete testing. The histological findings were similar in the patients who were serologically positive and those who were indeterminate for AG. In all of these cases, the oxyntic mucosa showed lymphoplasmacytic infiltrates within the lamina propria with focal gland infiltration and damage. Sixty-five percent (22/34) of the cases showed intestinal and/or pyloric metaplasia, and 85{\%} (29/34) showed parietal cell pseudohypertrophy. Chromogranin stains were performed in 11 of 13 cases with positive serological markers for AG, and all showed at least linear ECL cell hyperplasia. In contrast, none of the six cases with negative serological studies had linear ECL cell hyperplasia, P < .001. In conclusion, the following constellation of findings supports a diagnosis of AG before the complete loss of oxyntic mucosa: deep or diffuse lymphoplasmacytic infiltrates within the lamina propria with foci of gland infiltration and damage, epithelial metaplasia, parietal cell pseudohypertrophy, and ECL cell hyperplasia at the linear or greater level.",
keywords = "Autoimmune gastritis, Chromogranin, ECL-cell hyperplasia, Gastrin, Metaplasia, Stomach",
author = "Michael Torbenson and Abraham, {Susan C.} and John Boitnott and Yardley, {John H.} and Tsung-Teh Wu",
year = "2002",
doi = "10.1038/modpathol.3880499",
language = "English (US)",
volume = "15",
pages = "102--109",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Autoimmune gastritis

T2 - Distinct histological and immunohistochemical findings before complete loss of oxyntic glands

AU - Torbenson, Michael

AU - Abraham, Susan C.

AU - Boitnott, John

AU - Yardley, John H.

AU - Wu, Tsung-Teh

PY - 2002

Y1 - 2002

N2 - Autoimmune gastritis (AG) can be easily recognized when the histological features are fully developed, but recognizing AG before the complete loss of the oxyntic mucosa is more challenging. One feature of fully developed AG is enterochromaffin cell-like (ECL) hyperplasia, but its presence or absence in earlier stages of AG has not been fully evaluated. A retrospective study of biopsy specimens from 40 patients was performed; all of the patients were originally diagnosed with possible AG based on the presence of lymphocytic infiltration and damage to oxyntic glands and/or the presence of metaplastic epithelium that disproportionately involved the body mucosa. Nineteen cases had follow-up serological studies for anti-parietal cells and/or anti-intrinsic factor antibodies: 13 were positive and 6 negative. The remaining 21 cases were indeterminate because of incomplete testing. The histological findings were similar in the patients who were serologically positive and those who were indeterminate for AG. In all of these cases, the oxyntic mucosa showed lymphoplasmacytic infiltrates within the lamina propria with focal gland infiltration and damage. Sixty-five percent (22/34) of the cases showed intestinal and/or pyloric metaplasia, and 85% (29/34) showed parietal cell pseudohypertrophy. Chromogranin stains were performed in 11 of 13 cases with positive serological markers for AG, and all showed at least linear ECL cell hyperplasia. In contrast, none of the six cases with negative serological studies had linear ECL cell hyperplasia, P < .001. In conclusion, the following constellation of findings supports a diagnosis of AG before the complete loss of oxyntic mucosa: deep or diffuse lymphoplasmacytic infiltrates within the lamina propria with foci of gland infiltration and damage, epithelial metaplasia, parietal cell pseudohypertrophy, and ECL cell hyperplasia at the linear or greater level.

AB - Autoimmune gastritis (AG) can be easily recognized when the histological features are fully developed, but recognizing AG before the complete loss of the oxyntic mucosa is more challenging. One feature of fully developed AG is enterochromaffin cell-like (ECL) hyperplasia, but its presence or absence in earlier stages of AG has not been fully evaluated. A retrospective study of biopsy specimens from 40 patients was performed; all of the patients were originally diagnosed with possible AG based on the presence of lymphocytic infiltration and damage to oxyntic glands and/or the presence of metaplastic epithelium that disproportionately involved the body mucosa. Nineteen cases had follow-up serological studies for anti-parietal cells and/or anti-intrinsic factor antibodies: 13 were positive and 6 negative. The remaining 21 cases were indeterminate because of incomplete testing. The histological findings were similar in the patients who were serologically positive and those who were indeterminate for AG. In all of these cases, the oxyntic mucosa showed lymphoplasmacytic infiltrates within the lamina propria with focal gland infiltration and damage. Sixty-five percent (22/34) of the cases showed intestinal and/or pyloric metaplasia, and 85% (29/34) showed parietal cell pseudohypertrophy. Chromogranin stains were performed in 11 of 13 cases with positive serological markers for AG, and all showed at least linear ECL cell hyperplasia. In contrast, none of the six cases with negative serological studies had linear ECL cell hyperplasia, P < .001. In conclusion, the following constellation of findings supports a diagnosis of AG before the complete loss of oxyntic mucosa: deep or diffuse lymphoplasmacytic infiltrates within the lamina propria with foci of gland infiltration and damage, epithelial metaplasia, parietal cell pseudohypertrophy, and ECL cell hyperplasia at the linear or greater level.

KW - Autoimmune gastritis

KW - Chromogranin

KW - ECL-cell hyperplasia

KW - Gastrin

KW - Metaplasia

KW - Stomach

UR - http://www.scopus.com/inward/record.url?scp=0036182994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036182994&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3880499

DO - 10.1038/modpathol.3880499

M3 - Article

C2 - 11850538

AN - SCOPUS:0036182994

VL - 15

SP - 102

EP - 109

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 2

ER -